These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 7400756)

  • 41. Selectin and Lewis(x) are required as co-receptors in antibody-dependent cell-mediated cytotoxicity of human eosinophils to Schistosoma mansoni schistosomula.
    Nutten S; Papin JP; Woerly G; Dunne DW; MacGregor J; Trottein F; Capron M
    Eur J Immunol; 1999 Mar; 29(3):799-808. PubMed ID: 10092082
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decay accelerating factor (DAF) as the host antigen with protective activity to complement killing of schistosomula.
    Ramalho-Pinto FJ
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():213-6. PubMed ID: 2474124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional role of the alpha-chain of complement receptor type 3 in human eosinophil-dependent antibody-mediated cytotoxicity against schistosomes.
    Capron M; Kazatchkine MD; Fischer E; Joseph M; Butterworth AE; Kusnierz JP; Prin L; Papin JP; Capron A
    J Immunol; 1987 Sep; 139(6):2059-65. PubMed ID: 2957447
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complement-mediated killing of schistosomula of Schistosoma mansoni by rat eosinophils in vitro.
    Ramalho-Pinto FJ; McLaren DJ; Smithers SR
    J Exp Med; 1978 Jan; 147(1):147-56. PubMed ID: 627834
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Haptenation of adult Schistosoma mansoni and assessment of humorally mediated damage in vitro.
    McCormick SL; Damian RT
    J Parasitol; 1987 Feb; 73(1):130-43. PubMed ID: 3572646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Killing of schistosomula of Schistosoma mansoni coated with antibody and/or complement by human leukocytes in vitro: requirement for complement in preferential killing by eosinophils.
    Anwar AR; Smithers SR; Kay AB
    J Immunol; 1979 Feb; 122(2):628-37. PubMed ID: 762435
    [No Abstract]   [Full Text] [Related]  

  • 47. Mechanisms involved in the loss of antibody-mediated adherence of macrophages to lung-stage schistosomula of Schistosoma mansoni in vitro.
    Lawson BW; Bickle QD; Taylor MG
    Parasitology; 1993 Jun; 106 ( Pt 5)():463-9. PubMed ID: 8341582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neutrophil-mediated cytotoxicity to schistosomula of Schistosoma mansoni in vitro: studies on the kinetics of complement and/or antibody-dependent adherence and killing.
    Incani RN; McLaren DJ
    Parasite Immunol; 1981; 3(2):107-26. PubMed ID: 7243337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. H-2-restricted cytotoxic effectors generated in vitro by the addition of trinitrophenyl-conjugated soluble proteins.
    Schmitt-Verhulst AM; Pettinelli CB; Henkart PA; Lunney JK; Shearer GM
    J Exp Med; 1978 Feb; 147(2):352-68. PubMed ID: 75237
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo immunisation and reaction against TNP-modified splenocytes.
    Bischoff P; Oth D
    Nature; 1978 Aug; 274(5673):806-8. PubMed ID: 683318
    [No Abstract]   [Full Text] [Related]  

  • 51. Early developmental changes of the schistosomula of Schistosoma mansoni in vitro and in mouse lung.
    Imohiosen EA; Sher A; von Lichtenberg F
    Parasitology; 1978 Jun; 76(3):317-26. PubMed ID: 662413
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Maturation in vivo of Schistosoma mansoni schistosomula after culture in vitro with granulocytes and antibody.
    Dessein A; Butterworth AE; Vadas MA; David JR
    Infect Immun; 1983 Jan; 39(1):225-32. PubMed ID: 6822415
    [TBL] [Abstract][Full Text] [Related]  

  • 53. T-cell helper response to antigens of Schistosoma mansoni in CBA mice.
    Ramalho-Pinto FJ; Goldring OL; Smithers SR; Playfair HL
    Clin Exp Immunol; 1976 Nov; 26(2):327-33. PubMed ID: 791552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro proliferative response to living schistosomula by T lymphocytes from mice infected with Schistosoma mansoni.
    James SL
    Parasitology; 1981 Aug; 83(Pt 1):147-62. PubMed ID: 6973741
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immune response of guinea pigs to Schistosoma mansoni. I. In vitro effects of antibody and neutrophils, eosinophils and macrophages on schistosomula.
    Dean DA; Wistar R; Chen P
    Am J Trop Med Hyg; 1975 Jan; 24(1):74-82. PubMed ID: 1111359
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Schistosoma mansoni: escape from complement-mediated parasiticidal mechanisms following percutaneous primary infection.
    Ruppel A; McLaren DJ; Diesfeld HJ; Rother U
    Eur J Immunol; 1984 Aug; 14(8):702-8. PubMed ID: 6468491
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Decreasing immunogenicity of developing schistosome larvae.
    Sher A; Benno D
    Parasite Immunol; 1982 Mar; 4(2):101-7. PubMed ID: 7070833
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A lung model of schistosome immunity in mice.
    von Lichtenberg F; Sher A; McIntyre S
    Am J Pathol; 1977 Apr; 87(1):105-23. PubMed ID: 851162
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Schistosoma mansoni: in vitro and in vivo killing of antibody-coated schistosomula.
    Correa-Oliveira R; Mota-Santos TA; Gazzinelli G
    Am J Trop Med Hyg; 1982 Sep; 31(5):991-8. PubMed ID: 7125066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ultrastructural observations on the in vitro interaction of rat neutrophils with schistosomula of Schistosoma mansoni in the presence of antibody and/or complement.
    Incani RN; McLaren DJ
    Parasitology; 1983 Apr; 86 (Pt 2)():345-57. PubMed ID: 6856337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.